STOCK TITAN

Zentek Announces Test Results Validating ZenGUARD(TM) Enhanced Air Filters as a High-Performance Solution for ASHRAE Standard 241 Compliance

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Zentek (NASDAQ:ZTEK) announced positive test results for their ZenGUARD Enhanced Air Filters, demonstrating superior viral filtration efficiency against bacteriophage MS2. Independent testing by LMS Technologies showed ZenGUARD filters achieved 42% infectious aerosol removal efficiency compared to 16% for untreated filters. The technology complies with ASHRAE Standard 241-2023 for controlling infectious aerosols while maintaining energy efficiency. ZenGUARD's unique advantages include compatibility with existing HVAC systems, no additional equipment requirements, extended filter life, and reduced maintenance costs. The solution allows facilities to meet air quality standards without upgrading to MERV 11A or higher filters, offering a cost-effective approach to improving indoor air quality while reducing carbon emissions.
Zentek (NASDAQ:ZTEK) ha annunciato risultati positivi nei test dei loro filtri aria avanzati ZenGUARD, che hanno dimostrato un'efficienza superiore nella filtrazione virale contro il batteriofago MS2. Test indipendenti condotti da LMS Technologies hanno evidenziato che i filtri ZenGUARD raggiungono un'efficienza del 42% nella rimozione di aerosol infettivi, rispetto al 16% dei filtri non trattati. La tecnologia è conforme allo standard ASHRAE 241-2023 per il controllo degli aerosol infettivi, mantenendo al contempo l'efficienza energetica. I vantaggi unici di ZenGUARD includono la compatibilità con i sistemi HVAC esistenti, l'assenza di necessità di apparecchiature aggiuntive, una vita utile del filtro prolungata e costi di manutenzione ridotti. La soluzione consente alle strutture di rispettare gli standard di qualità dell'aria senza dover passare a filtri MERV 11A o superiori, offrendo un approccio economico per migliorare la qualità dell'aria interna e ridurre le emissioni di carbonio.
Zentek (NASDAQ:ZTEK) anunció resultados positivos en las pruebas de sus filtros de aire mejorados ZenGUARD, demostrando una eficiencia superior en la filtración viral contra el bacteriófago MS2. Pruebas independientes realizadas por LMS Technologies mostraron que los filtros ZenGUARD lograron una eficiencia del 42% en la eliminación de aerosoles infecciosos, en comparación con el 16% de los filtros sin tratar. La tecnología cumple con la norma ASHRAE 241-2023 para el control de aerosoles infecciosos, manteniendo la eficiencia energética. Las ventajas únicas de ZenGUARD incluyen compatibilidad con sistemas HVAC existentes, sin necesidad de equipos adicionales, mayor vida útil del filtro y reducción de costos de mantenimiento. La solución permite a las instalaciones cumplir con los estándares de calidad del aire sin necesidad de actualizar a filtros MERV 11A o superiores, ofreciendo un enfoque rentable para mejorar la calidad del aire interior y reducir las emisiones de carbono.
Zentek(NASDAQ:ZTEK)는 ZenGUARD 향상형 공기 필터의 긍정적인 테스트 결과를 발표하며, 박테리오파지 MS2에 대한 우수한 바이러스 여과 효율을 입증했습니다. LMS Technologies의 독립 테스트에서 ZenGUARD 필터는 처리되지 않은 필터의 16%에 비해 42%의 감염성 에어로졸 제거 효율을 달성했습니다. 이 기술은 감염성 에어로졸 제어를 위한 ASHRAE 표준 241-2023을 준수하면서 에너지 효율성을 유지합니다. ZenGUARD의 독특한 장점으로는 기존 HVAC 시스템과의 호환성, 추가 장비 불필요, 필터 수명 연장 및 유지보수 비용 절감이 있습니다. 이 솔루션은 시설이 MERV 11A 이상 필터로 업그레이드하지 않고도 공기 질 기준을 충족할 수 있게 하여, 실내 공기 질 개선과 탄소 배출 감소를 비용 효율적으로 달성할 수 있도록 합니다.
Zentek (NASDAQ:ZTEK) a annoncé des résultats positifs pour ses filtres à air améliorés ZenGUARD, démontrant une efficacité supérieure de filtration virale contre le bactériophage MS2. Des tests indépendants réalisés par LMS Technologies ont montré que les filtres ZenGUARD atteignent une efficacité de retrait des aérosols infectieux de 42 %, contre 16 % pour les filtres non traités. Cette technologie est conforme à la norme ASHRAE 241-2023 pour le contrôle des aérosols infectieux tout en maintenant l'efficacité énergétique. Les avantages uniques de ZenGUARD incluent la compatibilité avec les systèmes HVAC existants, l'absence de besoin d'équipements supplémentaires, une durée de vie prolongée des filtres et des coûts de maintenance réduits. Cette solution permet aux établissements de respecter les normes de qualité de l'air sans passer à des filtres MERV 11A ou supérieurs, offrant une approche économique pour améliorer la qualité de l'air intérieur tout en réduisant les émissions de carbone.
Zentek (NASDAQ:ZTEK) gab positive Testergebnisse für ihre ZenGUARD Enhanced Air Filters bekannt, die eine überlegene virale Filtrationseffizienz gegen Bakteriophagen MS2 zeigen. Unabhängige Tests von LMS Technologies zeigten, dass ZenGUARD-Filter eine infektiöse Aerosol-Entfernungseffizienz von 42 % erreichten, verglichen mit 16 % bei unbehandelten Filtern. Die Technologie entspricht dem ASHRAE Standard 241-2023 zur Kontrolle infektiöser Aerosole und gewährleistet dabei Energieeffizienz. Zu den einzigartigen Vorteilen von ZenGUARD gehören die Kompatibilität mit bestehenden HVAC-Systemen, keine zusätzlichen Geräteanforderungen, längere Filterlebensdauer und reduzierte Wartungskosten. Die Lösung ermöglicht es Einrichtungen, Luftqualitätsstandards zu erfüllen, ohne auf MERV 11A oder höhere Filter umzurüsten, und bietet einen kosteneffizienten Ansatz zur Verbesserung der Innenraumluftqualität bei gleichzeitiger Reduzierung der CO2-Emissionen.
Positive
  • ZenGUARD filters achieved 42% infectious aerosol removal efficiency vs 16% for untreated filters
  • Technology complies with new ASHRAE Standard 241-2023 requirements
  • Can be used with lower-rated MERV 9A filters, avoiding costly HVAC system upgrades
  • Reduces operational costs through extended filter life and lower maintenance requirements
  • No increase in energy consumption or carbon emissions
Negative
  • None.

Insights

Zentek's ZenGUARD filters demonstrate 2.6x better viral filtration than standard filters, potentially positioning them as a standout ASHRAE 241 compliance solution.

Zentek's latest third-party test results represent a significant technical validation for their ZenGUARD™ technology. The testing by ISO-certified LMS Technologies shows ZenGUARD Enhanced Air Filters achieving 42% infectious aerosol removal efficiency against MS2 bacteriophage, compared to just 16% for untreated filters—a 2.6x improvement.

What makes these results particularly noteworthy is their alignment with the new ASHRAE Standard 241-2023 for control of infectious aerosols. This standard has emerged as the benchmark for building operators seeking to reduce airborne virus transmission while managing energy consumption. The MS2 bacteriophage testing methodology used is specifically recognized by ASHRAE 241, giving these results direct applicability to real-world compliance scenarios.

The competitive advantage here is multi-dimensional. ZenGUARD's technology appears to achieve ASHRAE 241 compliance without the typical downsides of higher-rated filters: no increased pressure drop (which would require more energy), no need for equipment upgrades, and potentially extended filter life. This represents a rare triple-win of improved performance, maintained energy efficiency, and reduced operational costs.

Most compelling is that ZenGUARD can achieve a 42% EPR rating even when applied to lower-rated MERV 9A filters, whereas ASHRAE 241 assigns zero EPR to filters below MERV 11A. This suggests facility managers could implement ZenGUARD without upgrading existing HVAC systems to accommodate denser filters—potentially removing a significant barrier to adoption for building operators facing both indoor air quality mandates and carbon reduction targets.

GUELPH, ON / ACCESS Newswire / June 12, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company, is pleased to announce new independent test results comparing the viral filtration efficiency ("VFE") of ZenGUARD™ Enhanced Air Filters against the bacteriophage MS2 compared to equivalent Minimum Efficiency Reporting Value ("MERV")-rated filters without ZenGUARD™. The testing was performed by the third-party ISO 17025:2017 certified lab LMS Technologies Inc. ("LMS"), which specializes in the testing and certification of filter manufacturers across the world in line with American Society of Heating, Refrigerating and Air-Conditioning Engineers ("ASHRAE") standards.

Test Results

ZenGUARD™ Enhanced Air Filters achieved an average infectious aerosol removal efficiency (εPR) of MS2 bacteriophage of 42% compared to an untreated filter, which achieved an average εPR of 16%. These strong results align with previous tests performed with bacteriophage Phi6, which is often used as a surrogate for SARS-CoV-2 and other enveloped viruses.

This milestone adds to a growing body of third-party validation demonstrating ZenGUARD™ Enhanced Air Filter's unique combination of effectiveness and simplicity. To highlight this, the Company believes ZenGUARD™ Enhanced Air Filters are the only technology that can accomplish the following simultaneously:

  • Highly effective at controlling infectious aerosol in line with ASHRAE 241

  • Achieve this without an increase in pressure drop, energy consumption and carbon emissions

  • Work with existing heating, ventilation, and air conditioning units

  • Not require any additional equipment

  • Extend filter life and reduce changeout frequency compared to more dense filters reducing labour and waste disposal costs

ASHRAE Standard 241-2023: Control of Infectious Aerosols

ASHRAE Standard 241 is new guidance designed to help buildings reduce the spread of airborne viruses, like SARS-CoV-2, influenza, and other respiratory illnesses. It sets clear guidelines for Equivalent Clean Airflow ("ECA") (from ventilation, filtration, or air cleaning) that is needed to lower the risk of infection in indoor spaces. This is important because it gives schools, offices, and other public buildings a science-based way to improve indoor air quality and the health of building occupants. ASHRAE 241 focuses specifically on health and infection control, making it a key tool for creating safer indoor environments.

The standard includes the use of MS2 bacteriophage as a standardized surrogate for evaluating the control of infectious aerosol. Its inclusion ensures a consistent benchmark for assessing the effectiveness of technologies such as ZenGUARD™ Enhanced Air Filters.

Based on these new test results using MS2 bacteriophage, the Company now has science-based, directly comparable data demonstrating that ZenGUARD™ is highly effective at controlling infectious aerosols and is fully aligned with ASHRAE Standard 241 testing methodology.

ZenGUARD™'s higher εPR translates to a higher ECA, making it a practical and effective option for inclusion in building readiness plans prepared by facility managers and building operators.

Importantly, ASHRAE 241 assigns an εPR of zero to any filter rated below MERV 11A. However, ZenGUARD™, which has been independently tested with MS2, can be assigned an EPR of 42%, even when applied to a lower-rated MERV 9A filter. This allows facility managers to confidently adopt ZenGUARD™ technology without needing to upgrade to MERV 11A or higher filters, which may be incompatible with existing HVAC systems.

"These exciting new test results not only reinforce ZenGUARD™'s proven ability to improve indoor quality without increasing energy consumption - they highlight how our solution meets the requirements of ASHRAE 241, the most recent and relevant third-party guidance for controlling infectious aerosols in buildings," said Greg Fenton, CEO of Zentek Ltd. "Conventional panel filters - like electrostatically charged MERV 13s - are designed to trap dust and often fall short over time when it comes to impacting aerosols responsible for respiratory infections. In contrast, our filters were specifically designed to enhance mechanical filtration of infectious aerosol via the unique properties of our patented ZenGUARD™ technology - and we have now demonstrated our ability to do this in line with the only standard focused solely on infection control. As building operators face growing pressure to meet new air quality standards and carbon reduction targets, we're proud to offer our unique technology that is proven to effectively keep indoor spaces safe, while also reducing total cost of ownership and carbon emissions."

About Zentek Ltd.

Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.

Zentek's patented technology platform ZenGUARD™, is shown to significantly increase the bacterial and viral filtration efficiency for surgical masks and aims to do the same with HVAC (heating, ventilation, and air conditioning) filters Zentek's ZenGUARD™ production facility is in Guelph, Ontario.

Zentek, through its wholly owned subsidiary, Triera Biosciences Ltd., has a global exclusive licence to the aptamer-based platform technology developed by McMaster University, which is being jointly developed by Zentek and McMaster for both the diagnostic and therapeutic markets.

For further information:

investorrelations@zentek.com

Ryan Shacklock
Email: rshacklock@zentek.com
306-270-9610

To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.

Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Zentek Ltd.



View the original press release on ACCESS Newswire

FAQ

What efficiency rate did Zentek's ZenGUARD air filters achieve in MS2 bacteriophage testing?

ZenGUARD Enhanced Air Filters achieved a 42% infectious aerosol removal efficiency against MS2 bacteriophage, compared to 16% for untreated filters.

How does ZenGUARD technology comply with ASHRAE Standard 241-2023?

ZenGUARD meets ASHRAE 241 requirements by demonstrating effective infectious aerosol control using MS2 bacteriophage testing, achieving a 42% EPR even with MERV 9A filters, while maintaining energy efficiency.

What are the main advantages of Zentek's ZenGUARD air filtration technology?

ZenGUARD offers superior viral filtration, compatibility with existing HVAC systems, no additional equipment needs, extended filter life, reduced maintenance costs, and no increase in energy consumption or carbon emissions.

Can ZenGUARD filters be used with lower-rated MERV filters?

Yes, ZenGUARD can be used with lower-rated MERV 9A filters while still achieving a 42% EPR, eliminating the need for upgrading to MERV 11A or higher filters.

What is ASHRAE Standard 241-2023 and why is it important?

ASHRAE Standard 241-2023 is new guidance for reducing airborne virus spread in buildings by setting clear guidelines for Equivalent Clean Airflow from ventilation, filtration, or air cleaning to improve indoor air quality and occupant health.
Zentek Ltd

NASDAQ:ZTEK

ZTEK Rankings

ZTEK Latest News

ZTEK Stock Data

154.38M
97.96M
5.99%
1.66%
0.14%
Medical Instruments & Supplies
Healthcare
Link
Canada
Guelph